Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2020-09-23 Board/Management Inform…
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Oświadczenie Zarządu w sprawie rzetelności sporządzenia sprawozdania finansowego
Board/Management Information Classification · 99% confidence The document contains a 'STATEMENT OF THE MANAGEMENT BOARD ON THE RELIABILITY OF PREPARATION OF FINANCIAL STATEMENTS' (OŚWIADCZENIE ZARZĄDU W SPRAWIE RZETELNOŚCI SPORZĄDZENIA SPRAWOZDANIA FINANSOWEGO). It explicitly mentions the 'individual semi-annual financial statements of Mabion S.A. for a period of 6 months ending on June 30, 2020'. This content is characteristic of the formal declaration accompanying an interim financial report, which aligns with the definition of an Interim / Quarterly Report (IR). The date of the statement is September 22, 2020, confirming it relates to the H1 2020 results.
2020-09-23 Polish
Mabion_Sprawozdanie Zarządu
Interim / Quarterly Report Classification · 100% confidence The document is a 'Sprawozdanie Zarządu z działalności' (Management Board Report on Activities) for Mabion S.A. for the first half of 2020. It contains detailed financial data, balance sheets, income statements, and management commentary regarding the company's operations, board composition, and financial position. Since it covers a period shorter than a full fiscal year (first half/interim) and includes substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. H1 2020
2020-09-23 Polish
Mabion MSSF_1H2020
Interim / Quarterly Report Classification · 100% confidence The document is a 'Śródroczne Skrócone Sprawozdanie Finansowe' (Interim Condensed Financial Statement) for Mabion S.A. for the 6-month period ending June 30, 2020. It contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, and Statement of Cash Flows. As it provides substantive financial data for an interim period, it is classified as an Interim/Quarterly Report (IR). H1 2020
2020-09-23 Polish
Delegowanie członka Rady Nadzorczej do wykonywania czynności członka Zarządu - Content (EN)
Board/Management Information Classification · 100% confidence The document explicitly announces the assignment of a Supervisory Board member to the Management Board of Mabion S.A. It details the individual's appointment period and professional background. This type of announcement, concerning changes in the composition of the board of directors or senior management, directly corresponds to the definition of 'Board/Management Information' (MANG). The document is short and contains specific personnel change details, ruling out comprehensive reports like 10-K or IR.
2020-09-17 English
Delegowanie członka Rady Nadzorczej do wykonywania czynności członka Zarządu - Content (PL)
Board/Management Information Classification · 100% confidence The document text is a formal announcement in Polish by the Management Board ('Zarząd') of Mabion S.A. It details a resolution passed by the Supervisory Board ('Rada Nadzorcza') to delegate a member, Mr. Adam Pietruszkiewicz, to act as a member of the Management Board for a specified period (September 17, 2020, to December 17, 2020). It also provides a detailed biography and professional background of the individual involved in this change. This content directly relates to changes in the company's senior management/board structure. Therefore, the appropriate classification is Board/Management Information (MANG). The document is short and is an announcement of a change, not a comprehensive report.
2020-09-17 Polish
Zawarcie porozumienia dotyczącego potencjalnej współpracy w zakresie produktu mogącego stanowić szczepionkę na chorobę Covid-19 - Content (EN)
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the conclusion of a Memorandum of Understanding (MoU) concerning potential cooperation on a COVID-19 vaccine product (Covax-19™). It cites 'Article 17 (1) MAR - confidential information,' indicating it is a regulatory disclosure, likely related to material non-public information. This type of announcement—a specific, material corporate event disclosure that isn't a standard periodic report (10-K, IR), an earnings release (ER), or a director trade (DIRS)—falls best under the general 'Regulatory Filings' category, as it doesn't match the specific definitions for AGM-R, CT, CAP, DVA, DLST, SR, FS, CGR, IRAT, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. It is not an Earnings Release (ER) as it discusses a strategic agreement, not financial results. It is not a Report Publication Announcement (RPA) because it is the substance of the news, not just an announcement that a report is available. Therefore, RNS (Regulatory Filings) is the most appropriate fallback category for this material, non-standard regulatory disclosure.
2020-09-14 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.